Testosterone ketolaurate

Testosterone ketolaurate
Clinical data
Trade namesAndrodurin, Testosid-Depot
Routes of
administration		Intramuscular injection
Identifiers
  • (1S,2R,10R,11S,14S,15S)-2,15-dimethyl-5-oxotetracyclo[8.7.0.02,7.011,15]heptadec-6-en-14-yl 3-oxododecanoate
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.025.036 Edit this at Wikidata
Chemical and physical data
FormulaC31H48O4
Molar mass484.721 g·mol−1
3D model (JSmol)
  • CCCCCCCCCC(=O)CC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C
  • InChI=1S/C31H48O4/c1-4-5-6-7-8-9-10-11-23(32)21-29(34)35-28-15-14-26-25-13-12-22-20-24(33)16-18-30(22,2)27(25)17-19-31(26,28)3/h20,25-28H,4-19,21H2,1-3H3/t25-,26-,27-,28-,30-,31-/m0/s1
  • Key:LTGBMQYUNNUCHA-DQUDHZTESA-N

Testosterone ketolaurate (INN, USAN) (brand names Androdurin, Testosid-Depot (with testosterone propionate)), also known as testosterone caprinoylacetate, is an androgen and anabolic steroid medication and a testosterone ester.[1][2][3] It was introduced in 1956.[4] It was marketed both as an oil solution and as a crystalline aqueous suspension.[5]

  1. ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 641–642. ISBN 978-1-4757-2085-3.
  2. ^ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. ISBN 978-3-88763-075-1.
  3. ^ Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. ISBN 978-94-011-4439-1.
  4. ^ United States. Patent Office (1956). Official Gazette of the United States Patent Office. U.S. Patent Office.
  5. ^ Jores A, Nowakowski H (1960). Praktische Endokrinologie. G. Thieme. p. 297.